The market for Downstream Processing Market is anticipated to grow at a CAGR of 11.3% between 2022 and 2032, reaching a market valuation of US$ 72.3 Bn by the end of 2032. The global downstream processing market size was valued at US$ 22.0 Bn in 2021 and is anticipated to enjoy a valuation of US$ 24.9 Bn …
Category Archives: Healthcare Trends
Competent Cells Market is expected to reach US$ 5.9 Bn by 2032, with sales revenue expected to register an 11.1% CAGR
By the end of 2022, the Competent Cells Market is anticipated to reach US$ 2.1 billion, growing at a double-digit rate of 11.1% CAGR (2022-2032). By 2032, the market’s sales are projected to be worth $5.9 billion USD. Chemically competent cells held the market’s top spot in terms of product type in 2021, with a …
Monoclonal Antibodies Market is expected to reach US$ 647.01 Billion by 2032 at a CAGR of 12 %
The global Monoclonal Antibodies Market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion by 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%. Human mAbs …
Soft Tissue Repair Market | Wright Medical Group N.V., Integra LifeScience Corporation, Medtronic Plc, CONMED Corporation | By 2032
The global Soft Tissue Repair Market is anticipated to reach US$ 6.61 billion in 2022 and grow at a CAGR of 5.8% from 2022 to 2032. By 2032, market sales are anticipated to be worth US$ 11.66 billion. Based on region, North America held a 34.2% demand share of the global soft tissue repair market …
Biopharmaceutical Contract Manufacturing Market | Catalent Inc., Lonza Group Ag, Patheon N.V., Abzena Plc. | By 2029
Global Biopharmaceutical Contract Manufacturing Market was estimated to be worth roughly US$ 8.4 billion in 2021 and is expected to grow at a CAGR of 10.5% to reach US$ 18.7 billion by 2029. A few benefits provided by biopharmaceutical manufacturing businesses include access to pricey technologies, a shorter overall time to market investment for new pharmaceuticals, and increased flexibility. Several multinational corporations …
Fungal Testing Kits Market is expected to rise at a robust CAGR of 10.1% from 2023 to 2033
With a projected fungal testing kits market size of over US$ 1.72 billion as of 2023, the global fungus testing equipment market is to expand significantly between 2023 and 2033, growing at a rate of 10.1% CAGR and achieving US$ 4504 million by 2033. Diagnostic laboratories are to command a sizeable market share of more than …
Brain Tumor Drugs Market is expected to record a CAGR of 9.2% during the 2023 to 2033
The Brain Tumor Drugs Market is likely to grow from US$ 2.65 billion in 2023 to US$ 6.30 billion in 2033, at a CAGR 9.2%. Growing Use of Targeted Medicines is Putting a Damper on the Brain Tumor Medications Industry The goal of targeted cancer therapy is to eliminate cancerous cells while leaving healthy cells …
Spine Pain Market is expected to garner a value of US$ 12.47 Billion by 2033
According to Future Market Insights’ recent report, the spine pain market is forecast to register a CAGR of 5% from 2023 to 2033, reaching a valuation of US$ 12.47 Billion. Anti-inflammatory medications’ minor side effects are encouraging an increase in their usage as pain relievers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as …
Continue reading “Spine Pain Market is expected to garner a value of US$ 12.47 Billion by 2033”
Durable Medical Equipment Rental Market is expected to reach US$ 47 billion by 2033
According to a newly released Durable Medical Equipment Rental Market analysis report by Future Market Insights, revenue from the Durable Medical Equipment Rental Market in 2022 is expected to be US$ 25.7 billion. The market is expected to reach a valuation of US$ 47 billion by 2033, with a CAGR of 5.7% from 2023 to …
Edward’s Syndrome Treatment Market is expected to reach US$ 7.98 Billion by 2033
During the forecast period 2023 to 2033, the Edward’s syndrome treatment market is expected to grow at a value of 5% CAGR, according to Future Market Insights. By the year 2033, the global market for Edward’s syndrome treatment is expected to rise up to a market valuation of US$ 7.98 Billion. Growth of the market …
Continue reading “Edward’s Syndrome Treatment Market is expected to reach US$ 7.98 Billion by 2033”